Milić S, Lulić D, Štimac D. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. World J Gastroenterol. 2014;20:9330–7.
Polyzos SA, Kountouras J, Mantzoros CS. Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics. Metab: Clin Exp. 2019;92:82–97.
Machado MV, Cortez-Pinto H. Diet, microbiota, obesity, and NAFLD: a dangerous quartet. Int J Mol Sci. 2016;17:1–20.
Cross SJ, Linker KE, Leslie FM. Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters. Physiol Behav. 2016;176:100–6.
Li L, Liu DW, Yan HY, Wang ZY, Zhao SH, Wang B. Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies. Obes Rev. 2016;17:510–9.
Castera L, Friedrich-Rus M, Loomba R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Physiol Behav. 2017;176:139–48.
Rheinwalt KP, Drebber U, Schierwagen R, Klein S, Neumann UP, Ulmer TF, et al. Baseline presence of nafld predicts weight loss after gastric bypass surgery for morbid obesity. J Clin Med. 2020;9:1–12.
Wagner KT, Randall JA, Zimmermann J, Khambaty F, Brody F. Effects of liver pathology on sleeve gastrectomy outcomes. J Laparoendosc Adv Surg Tech. 2022;32:310–4.
Lassailly G, Caiazzo R, Ntandja-Wandji LC, Gnemmi V, Baud G, Verkindt H, et al. Bariatric surgery provides long-term resolution of nonalcoholic steatohepatitis and regression of fibrosis. Gastroenterology. Am Gastroenterol Assoc. 2020;159:1290-1301.e5.
Bhagwandin C, Ashbeck EL, Whalen M, Bandola-Simon J, Roche PA, Szajman A, et al. The E3 ubiquitin ligase MARCH1 regulates glucose-tolerance and lipid storage in a sex-specific manner. PLoS ONE. 2018;13:1–14.
Rauschert S, Uhl O, Koletzko B, Mori TA, Beilin LJ, Oddy WH, et al. Sex differences in the association of phospholipids with components of the metabolic syndrome in young adults. Biol Sex Differ. 2017;8:1–13.
Brunt EM, Janney CG, Di Bisceglie MA, Neuschwander-Tetri B, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467–74.
Campos GM, Rabl C, Mulligan K, Posselt A, Rogers SJ, Westphalen AC, et al. Factors associated with weight loss after gastric bypass. Arch Surg. 2008;143:877–83.
Melton GB, Steele KE, Schweitzer MA, Lidor AO, Magnuson TH. Suboptimal weight loss after gastric bypass surgery: correlation of demographics, comorbidities, and insurance status with outcomes. J Gastrointest Surg: official journal of the Society for Surgery of the Alimentary Tract United States. 2008;12:250–5.
Fernández-Ananín S, Ballester E, Gonzalo B, Codina C, Miñambres I, Pérez A, et al. Is sleeve gastrectomy as effective in older patients as in younger patients? A comparative analysis of weight loss, related comorbidities, and medication requirements. Obes Surg. 2022;32:1909–17.
Abbassi Z, Orci L, Meyer J, Sgardello SD, Goossens N, Rubbia-Brandt L, et al. Impact of nonalcoholic steatohepatitis on the outcome of patients undergoing Roux-en-Y gastric bypass surgery: a propensity score-matched analysis. Obes Surg. 2021;32:74–81.
Kalinowski P, Paluszkiewicz R, Ziarkiewicz-Wróblewska B, Wróblewski T, Remiszewski P, Grodzicki M, et al. Liver function in patients with nonalcoholic fatty liver disease randomized to Roux-en-Y gastric bypass versus sleeve gastrectomy: a secondary analysis of a randomized clinical trial. Ann Surg United States. 2017;266:738–45.
de Brito E, Silva MB, Tustumi F, de Miranda Neto AA, Dantas ACB, Santo MA, Cecconello I. Gastric bypass compared with sleeve gastrectomy for nonalcoholic fatty liver disease: a systematic review and meta-analysis. Obes Surg. 2021;31:2762–72.
Beisani M, Sabench Pereferrer F, Vilallonga R, González López Ó, Molina López A, Del Castillo Dejardin D, et al. Seeking an initial-weight-independent metric in a Mediterranean cohort of gastric bypass patients: the %AWL revisited. Obes Surg. 2021;31:1524–32.
van de Laar AW, Emous M, Hazebroek EJ, Boerma E-J, Faneyte IF, Nienhuijs SW. Reporting weight loss 2021: position statement of the Dutch Society for Metabolic and Bariatric Surgery (DSMBS). Obes Surg United States. 2021;31:4607–11.
van de Laar AW, van Rijswijk AS, Kakar H, Bruin SC. Sensitivity and specificity of 50% excess weight loss (50%EWL) and twelve other bariatric criteria for weight loss success. Obes Surg United States. 2018;28:2297–304.
Baltasar A, Perez N, Serra C, Bou R, Bengochea M, Borrás F. Weight loss reporting: predicted body mass index after bariatric surgery. Obes Surg United States. 2011;21:367–72.
Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism: Clinical and Experimental. Elsevier Inc.; 2016;65:1038–48.
Franchitto A, Carpino G, Alisi A, De Peppo F, Overi D, De Stefanis C, et al. The contribution of the adipose tissue-liver axis in pediatric patients with nonalcoholic fatty liver disease after laparoscopic sleeve gastrectomy. J Pediatr Elsevier. 2020;216:117-127.e2.
Cerreto M, Santopaolo F, Gasbarrini A, Pompili M, Ponziani FR. Bariatric surgery and liver disease: general considerations and role of the gut-liver axis. Nutrients. 2021;13:1–24.
Garciacaballero M, Reyes-Ortiz A, García M, Martínez-Moreno JM, Toval JA, García A, et al. Changes of body composition in patients with BMI 23–50 after tailored one anastomosis gastric bypass (BAGUA): influence of diabetes and metabolic syndrome. Obes Surg. 2014;24:2040–7.
Armandi A, Schattenberg JM. Beyond the paradigm of weight loss in non-alcoholic fatty liver disease: from pathophysiology to novel dietary approaches. Nutrients. 2021;13:1–23.
Ryan MC, Itsiopoulos C, Thodis T, Ward G, Trost N, Hofferberth S, et al. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J Hepatol Netherlands. 2013;59:138–43.
Scragg J, Avery L, Cassidy S, Taylor G, Haigh L, Boyle M, et al. Feasibility of a very low calorie diet to achieve a sustainable 10% weight loss in patients with nonalcoholic fatty liver disease. Clin Transl Gastroenterol. 2020;11:e00231.